article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

The FDA Law Blog

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance. Increased Connections Between a DMC and FDA?

FDA 105
article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

pharmaphorum

This review will include key documents such as minutes of management review meetings and quality metrics which will enable them to quickly assess the company’s approach to quality and compliance and the current level of control. In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 steps for comprehensive patient collaboration

pharmaphorum

Through this outcomes measurement tool, patients keep comprehensive diaries of their condition, documenting what aspects of the disease affect them most. In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community.

article thumbnail

Etomidate for RSI: Seizure Considerations

Pharmacy Friday Pearls

Zuckerbraun et al, 2006 Retrospective N=101 Etomidate for RSI in general population There was no relationship between seizures after etomidate administration and prior seizure history (p = 0.25). There were no cases of documented myoclonus, status epilepticus, or new-onset seizures. 2006 Jun;13(6):602-9. 2018 Oct;61:170-176.

article thumbnail

Draft LASIK Guidance: Why Did FDA Issue New Labeling Recommendations for Products that Already Have PMA Approved Labeling?

The FDA Law Blog

The introductory paragraph states: The review and understanding of this document is a critical step in making the decision whether you should choose LASIK surgery. Your full signature at the end of this document means that you have read and understood the materials and that your physician has answered all questions to your satisfaction.

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

2006: Congress passed, and President George W. The investigation, which included inquiries requesting large amounts of documents and communications from various stakeholders, is largely perceived as a drug industry-friendly fact-finding exercise. 340B providers expressed significant concern.

article thumbnail

Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict

Pharmaceutical Technology

But the EU draft document says that the changes will make medicines more affordable, improve unequal access to medicines across the EU, and fulfil unmet patient needs. The post Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict appeared first on Pharmaceutical Technology.